The pharmaceutical industry faces complex challenges—ranging from rapidly changing technologies to balancing patient needs with commercial interests. Recent reports show that while pharma companies are heavily investing in R&D, with expenditure ranging from around 14% to 50% of their revenues, only a small fraction of these efforts translates into groundbreaking therapies that reach patients. Additionally, as healthcare systems become more complex, there is a growing need for a patient-centric approach that balances innovation with operational efficiency, always keeping the patient at the center of these efforts.